Oral therapeutic agents in fungal nail disease (Q40698012)

22 September 2017

1 reference

title

Oral therapeutic agents in fungal nail disease (English)

1 reference

22 September 2017

Roberts DT

1

1 reference

PubMed ID

8077514

22 September 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

Journal of the American Academy of Dermatology

22 September 2017

1 reference

22 September 2017

31

1 reference

22 September 2017

3 Pt 2

1 reference

22 September 2017

S78-81

1 reference

Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

In vitro activity of terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Determination of terbinafine in nail samples during systemic treatment for onychomycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Mycological and clinical evaluation of griseofulvin for chronic onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Treatment of onychomycosis with terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Short term treatment of dermatophyte onychomycosis with terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

A randomized treatment duration-finding study of terbinafine in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

New approaches to the treatment of onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Candida onychomycosis--an evaluation of the role of Candida species in nail disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

Hepatic reactions during ketoconazole treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981274-1

7 January 2021

10.1016/S0190-9622(08)81274-1

Identifiers

DOI

0 references

PubMed ID

8077514

1 reference

PubMed ID

8077514